Chlamydia infection and respiratory disorders
InterCollegas. - Vol. 1, N1, 2014
PDF

How to Cite

Kuznetcov, S., Kucherenko, O., Zharkova, T., & Kucherenko, M. (2014). Chlamydia infection and respiratory disorders. Inter Collegas, 1(1), 116-131. https://doi.org/10.35339/ic.1.1.116-131

Abstract

CHLAMYDIA INFECTION AND RESPIRATORY DISORDERS Kuznetcov S., Kucherenko O., Zharkova T., Kucherenko M. Kharkiv national medical university, Kharkiv, Ukraine Abstract. Three chlamydial organisms are pathogenic to humans: C.pneumoniae, C.psittaci, and C.trachomatis. Clinical picture of chlamidiosis determine by species of the microbe. Efficiency of the treatment depends on timely and adequate therapy. Keywords: Chlamydia, pneumonia, infection. ХЛАМІДІНА ІНФЕКЦІЯ ТА РЕСПІРАТОРНІ ЗАХВОРЮВАННЯ Кузнєцов С.В., Кучеренко О.О., Жаркова Т.С., Кучеренко М.В. Харківський національний медичний університет, м. Харків, Україна Резюме. Розрізнюють три види хламідій: C.psitacci, C.рneumoniaе, C.trahomatis. Клінічна картина хламідіоза визначається видом збудника. Ефективність лікування залежить від своєчасної та адекватної терапевтичної тактики. Ключові слова: хламідія, пневмонія, інфекція. ХЛАМИДИЙНАЯ ИНФЕКЦИЯ И РЕСПИРАТОРНЫЕ ЗАБОЛЕВАНИЯ Кузнецов С.В., Кучеренко Е.О., Жаркова Т.С., Кучеренко М.В. Харьковский национальный медицинский университет, г. Харьков, Украина Резюме. Различают три вида хламидий: C.psitacci, C.рneumoniaе, C.trahomatis. Клиническая картина хламидиоза заболевания определяется видом возбудителя. Эффективность лечения зависит от своевременной и адекватной терапевтической тактики. Ключевые слова: хламидия, пневмония, инфекция.

https://doi.org/10.35339/ic.1.1.116-131
PDF

References

Aberle J.H. Single versus dual respiratory virus infections in hospitalized infants: Impact on clinical course of disease and interferon-response. / J.H. Aberle, S.W. Aberle, E. Pracher // Pediatric Infectious Disease Journal. – 2005. —V. 24. — P. 605–610.

About problem of chlamidiosis infection. / L.M. Sladkova, S.A. Rizenko, I.Yu.Stetsenko [et al.] // Annals of Mechnicov’s Institute. – 2005. — № 2. – P. 59 –63.

An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia. / P.I. Lee, M.H. Wu, L.M. Huang [et al.] // Journal of Microbiology, Immunology and Infection. – 2008. – P. 41–54.

Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. / L.A. Jackson, S.P. Wang, V. Nazar-Stewart [et al.] //Cancer Epidemiology, Biomarkers & Prevention.–2000. — V. 9. — P. 1263 – 1266.

Bennedsen M.Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. / M.Bennedsen, Berthelsen L., I. Lind. // Clinical and Diagnostic Laboratory ImmunologyJournal.– 2002.– V. 9. — P. 833−839.

Blasi F.Chlamydia pneumoniae: crossing the barriers? / F. Blasi, S. Centanni, L. Allegra // European Respiratory Journal. – 2004. — V. 23. — P. 499–500.

Byrne G.I. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. / G.I. Byrne, D.M. Ojcius // Nature reviews. Microbiology Journal. – 2004. —V. 2. — P. 802 – 808.

Byrne G.I. Chlamydia uncloaked. / G.I. Byrne // Proceedings of the National Academy of Sciences Journal. – 2003. —V. 100— P. 8040–8042.

Characterization of Chlamydia isolated from human patients in Germany over a 3-year period. / L. Beutin, G. Krause, S. Zimmermann [et al.] // Journal of Clinical Microbiology. – 2004. – № 42. – P. 1099 – 1108.

Characterization of host cell death induced by Chlamydia trachomatis. / S. Ying, S.F. Fischer, M. Pettengill [et al.] // Infection and Immunity. — 2006. — V. 74. — P. 6057–6066.

Chlamydia Lung Infection / J. Rodrigues, C.M.Thomazini, A.Morelli [et al.] // Journal of Clinical Microbiology. – 2003. – № 42. – Р. 398 – 400.

Сhlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. / N. H.Birkebaek, J. S. Jensen, T. Seefeldt [et al.] //European Respiratory Journal. —2000. —V. 16. — P. 108 —111.

Chlamydia pneumonia inhibitis apoptosis in human epithelial and monocyte cell lines./ S.Airenne, H.M.Surcel, J. Tuukkanen [et al.] // Scandinavian Journal of Immunology. – 2002. – V. 55. – №4. — P. 390−398.

Chlamydophila pneumoniae myopericarditis in a child. / M.Suesaowalak, M.M.Cheung, D. Tucker [et al.] // Pediatric Cardiology. — 2009. — 30. —P. 336.

Chlamydia (Chlamydophila) pneumoniae. / L.A. Jackson, G.L.Mandell, J.E.Bennett [et al.]. Principles and Practice of Infectious Diseases. – Philadelphia: Elsevier, 2005. — V. 6. — 205p.

Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. / N.J. Wald, M.R. Law, J.K. Morris [et al.] // British Medical Journal. – 2000. – V. 321. – P. 204 – 207.

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment./ J. Gieffers, H. Fullgraf, J. Jahn [et al.] // Circulation. – 2001. – № 103.– Р. 351–356.

Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis / G. Zandbergen, J. Gieffers, H. Kothe [et al.] // Journal of Immunology. — 2004. — V. 172. — P. 1768–1776.

Chlamydia pneumonia. / M.R. Hammerschlag,R.D.Feigin, J.D. Cherry [et al.]. Textbook of PediatricInfectious Diseases Journal.– Philadelphia:Elsevier, 2009.– V. 6.–1676p.

Chlamydia pneumoniae in children undergoing adenoidectomy. / E. Norman, J. Gnarpe, J. Naas [et al.] // Acta Paediatrica Journal. — 2007. — V. 90. — №2. — P. 126–129.

Chlamydia pneumonia in children. / D. Mahalanabis, A.S. Faruque, S.S. Hoque [et al.] // Acta Paediatrica Scandinavica Journal.– 2008. – №84. – Р. 289 – 293.

Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. / J. Rupp, T. Hellwig-Burgel, V. Wobbe [et al.] // Proceedings of the National Academy of Sciences of the United States of America. – 2005. – V. 102. – Р. 3447–3452.

Chlamydia polipeptide. / E. Salazar-Lindo, J. Santisteban-Ponte, E. Chea-Woo [et al.] // New England Journal of Medicine. – 2007. – V. 343. – P. 463–467.

Chlamydia pneumoniaserology: importance of methodology in patients with coronary heart disease and healthy individuals. / A. Schumacher, A.B. Lerkerod, I. Seljeflot [et al.] // Journal of Clinical Microbiology. —2001. — V. 39. — P. 1859–1864.

Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. / R.W. Peeling, S.P. Wang, J.T. Grayston [et al.] // Journal of Infectious Diseases– 2000. – V. 181(3). — P. 426–429.

Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. / U. Dreses-Werringloer, H.C. Gerard, J.A.Whittum-Hudson [et al.] // American Journal of the Medical Sciences. – 2006. – V. 332. – Р. 168 – 174.

Chlamydia trachomatis respiratory infection in Dutch infants. / G.I. Rours, M.R. Hammerschlag, G.J. Van Doornum [et al.] // Archives of Disease in Childhood – 2009. – V. 94. – P. 705.

Choice S.G. Immunological cells in patients with Chlamydia pneumonia / S.G. Choice // Pediatrics Journal. – 2001. − № 107. – Р. 613 − 618.

Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children./ J.Kuypers, N. Wright, J. Ferrenberg [et al.] //Journal of Clinical Microbiology. – 2006. – V. 44. – P. 2382–2388.

Comparison of Two Commercial Microimmunofluorescence Kits and an Enzyme ImmunoassayKit for Detection of Serum Immunoglobulin G Antibodies to Chlamydia pneumonia. / T.O. Messmer, J. Martinez, F. Hassouna [et al.] // Clinical and Vaccine Immunology. — 2007. — V. 8. —№3. — P. 588– 592.

Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. / F. Cirino, W.C. Webley, C. West [et al.] // BMC Infectious DiseasesJournal. – 2006. – V. 6. – 23р.

Diagnosis of Chlamydia pneumoniain community-acquired pneumonia in children. / C. Hedberg, S. Savarino, J. Besser [et al.] //Journal of Infectious Diseases. – 2008. —№ 176. — P. 1625 − 1628.

"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.

Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.